IPO Trending
INFINIUMSME / NSEListed

Infinium Pharmachem Limited

Incorporated in 2003, Infinium Pharmachem Limited manufactures and supplies Iodine Derivatives, APIs, and iodination reaction-based bulk drugs. The company offers R&D services along with commercial-scale manufacturing and packaging for the pharmaceutical, agrochemical, nutraceutical, specialty chemicals, and other chemical industries. Its FDA-certified and GMP-compliant manufacturing facility in Gujarat spans 4,100 sq. m and is equipped to produce complex iodine derivatives. Infinium Pharmachem serves over 15 countries globally, offering more than 200 iodine derivatives and 7 APIs.

₹135 - ₹1351.84x sub
Listed Price141.50
Listing Gain+4.81%
FinancialsBalance sheet and operational figures in Crores
Metric Breakdown

Revenue

Latest (Mar 2020)3941.64 Cr
Growth-50.6%
Revenue Trend (₹ in Crores)
0.03.8k7.7k11.5kSep 2022Mar 2022Mar 2021Mar 2020
PeriodRev (Cr)PAT (Cr)AssetsDebt
Mar 20203,941.6493.402,244.60566.17
Mar 20217,115.37272.483,418.27579.47
Mar 202210,005.25610.64 5,899.951,385.01
Sep 20227,985.39551.017,075.711,614.71
Infinium Pharmachem Limited IPO Financials | GMP, Allotment & Financials | IPO Trending